Daggett said the company is hiring and eager to dramatically increase the employee count. AltPep leadership includes Patrik Edenholm, chief operating officer; Chuck Horne, chief financial officer; and Kurt Becker, vice president of business development and legal. AltPep's three current board members — Daggett; Chad Robins, CEO of Adaptive Biotechnologies; and Todd Patrick, CEO of Armata Pharmaceuticals — are being joined by David Goel of Matrix Capital Management and Joel Marcus of Alexandria Real Estate Equities/Alexandria Venture Investments. Matrix Capital Management led the recent investment round with participation by Alexandria Venture Investments.